Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Mar;55(3):315–319. doi: 10.1038/bjc.1987.62

Long survival in childhood lymphoblastic leukaemia.

J M Chessells, R M Hardisty, S Richards
PMCID: PMC2001765  PMID: 3471266

Abstract

Long term follow-up of 378 children with acute lymphoblastic leukaemia (ALL) treated at a single centre showed that at six years from diagnosis 202 (53%) were alive, of whom 140 (37%) remained in first remission. Only three children had a first relapse after six years. Children who survived six years despite a single extramedullary relapse in the testis or CNS were likely to remain in second remission but patients with previous marrow or with multiple relapses continued at risk for up to ten years from diagnosis. Presenting factors influencing event-free survival were: leucocyte count, age and sex. After allowing for these factors morphological (FAB) subtype and liver enlargement retained their prognostic significance. Immunological type of ALL was not of independent prognostic significance, except for the small number of patients with B-ALL. Most factors lost their significance after 2-4 years. It is concluded that patients alive 6 years from diagnosis without relapse or even with a single extramedullary relapse of ALL, have a high chance of prolonged survival and cure.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  2. Chessells J. M., Cornbleet M. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL). Med Pediatr Oncol. 1979;6(4):359–365. doi: 10.1002/mpo.2950060413. [DOI] [PubMed] [Google Scholar]
  3. Chessells J. M., Hardisty R. M., Rapson N. T., Greaves M. F. Acute lymphoblastic leukaemia in children: Classification and prognosis. Lancet. 1977 Dec 24;2(8052-8053):1307–1309. doi: 10.1016/s0140-6736(77)90361-0. [DOI] [PubMed] [Google Scholar]
  4. Chessells J. M., Rogers D. W., Leiper A. D., Blacklock H., Plowman P. N., Richards S., Levinsky R., Festenstein H. Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia. Lancet. 1986 May 31;1(8492):1239–1241. doi: 10.1016/s0140-6736(86)91387-5. [DOI] [PubMed] [Google Scholar]
  5. Chessells J., Leiper A., Rogers D. Outcome following late marrow relapse in childhood acute lymphoblastic leukemia. J Clin Oncol. 1984 Oct;2(10):1088–1091. doi: 10.1200/JCO.1984.2.10.1088. [DOI] [PubMed] [Google Scholar]
  6. Crist W., Boyett J., Roper M., Pullen J., Metzgar R., van Eys J., Ragab A., Starling K., Vietti T., Cooper M. Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group study. Blood. 1984 Feb;63(2):407–414. [PubMed] [Google Scholar]
  7. George S. L., Aur R. J., Mauer A. M., Simone J. V. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979 Feb 8;300(6):269–273. doi: 10.1056/NEJM197902083000601. [DOI] [PubMed] [Google Scholar]
  8. Greaves M. F., Janossy G., Peto J., Kay H. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol. 1981 Jun;48(2):179–197. [PubMed] [Google Scholar]
  9. Gribbin M. A., Hardisty R. M., Chessells J. M. Long-term control of central nervous system leukaemia. Arch Dis Child. 1977 Sep;52(9):673–678. doi: 10.1136/adc.52.9.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hann I. M., Evans D. I., Palmer M. K., Morris-Jones P. J., Haworth C. The prognostic significance of morphological features in childhood acute lymphoblastic leukaemia. Clin Lab Haematol. 1979;1(3):215–226. doi: 10.1111/j.1365-2257.1979.tb00470.x. [DOI] [PubMed] [Google Scholar]
  11. Hardisty R. M., Till M. M., Peto J. Acute lymphoblastic leukaemia: four-year survivals old and new. J Clin Pathol. 1981 Mar;34(3):249–253. doi: 10.1136/jcp.34.3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Miller D. R., Leikin S., Albo V., Sather H., Hammond D. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol. 1981 Jun;48(2):199–206. [PubMed] [Google Scholar]
  13. Miller D. R., Leikin S., Albo V., Vitale L., Sather H., Coccia P., Nesbit M., Karon M., Hammond D. Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):381–392. [PubMed] [Google Scholar]
  14. Nesbit M. E., Jr, Sather H. N., Robison L. L., Ortega J. A., Hammond G. D. Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia. J Clin Oncol. 1983 May;1(5):308–316. doi: 10.1200/JCO.1983.1.5.308. [DOI] [PubMed] [Google Scholar]
  15. Pinkerton C. R., Chessells J. M. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome. Br J Haematol. 1984 Aug;57(4):553–561. [PubMed] [Google Scholar]
  16. Rapson N. T., Cornbleet M. A., Chessells J. M., Bennett A. J., Hardisty R. M. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. Br J Haematol. 1980 May;45(1):41–52. doi: 10.1111/j.1365-2141.1980.tb03809.x. [DOI] [PubMed] [Google Scholar]
  17. Sather H., Coccia P., Nesbit M., Level C., Hammond D. Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group. Cancer. 1981 Jul 15;48(2):370–376. doi: 10.1002/1097-0142(19810715)48:2<370::aid-cncr2820480224>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  18. Tiedemann J., Chessells J. M., Sandland R. M. Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome. Br Med J (Clin Res Ed) 1982 Dec 4;285(6355):1614–1616. doi: 10.1136/bmj.285.6355.1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Till M. M., Hardisty R. M., Pike M. C. Long survivals in acute leukaemia. Lancet. 1973 Mar 10;1(7802):534–538. doi: 10.1016/s0140-6736(73)90342-5. [DOI] [PubMed] [Google Scholar]
  20. Willoughby M. L. Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial. Br Med J. 1976 Apr 10;1(6014):864–867. doi: 10.1136/bmj.1.6014.864. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES